Clinical Trials Browser

Neoplasms, Venous Thromboembolism

NCT07160686 2025-09-08

THROMBO-STOP

Phase 3 Not yet recruiting

1,456 enrolled

Thromboprophylaxis

NCT02066454 2025-08-13

MYELAXAT

Phase 3 Completed

108 enrolled

Classical hematologyPlasma cell

Neoplasms, Plasma Cell, Venous Thromboembolism

NCT03045406 2025-06-24

CARAVAGGIO

Phase 3 Completed

1,170 enrolled 11 charts

Classical hematology

Venous Thromboembolism

NCT03080883 2025-05-18

Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy

Phase 3 Completed

370 enrolled 16 charts

Other hematologic neoplasm

Neoplasm Metastasis, Pulmonary Embolism, Hematologic Neoplasms, Venous Thrombosis, Intracranial Thrombosis

NCT03692065 2025-02-06

API-CAT

Phase 3 Completed

1,766 enrolled

Neoplasms, Thrombosis

NCT02585713 2020-08-04

Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism

Phase 3 Completed

300 enrolled 11 charts

Classical hematology

Neoplasm Metastasis, Neoplasms, Pulmonary Embolism, Venous Thrombosis, Intracranial Thrombosis, Venous Thromboembolism, Mesenteric Ischemia

NCT04462003 2020-07-08

DVT

Phase 3 Unknown

100 enrolled

Neoplasms, Venous Thrombosis

Clinical Trials

DOAC

THROMBO-STOP

MYELAXAT

CARAVAGGIO

Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy

API-CAT

Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism

DVT